Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci. 2002;14:223–36. https://doi.org/10.1176/jnp.14.2.223.

Article  PubMed  Google Scholar 

Dexter DT, Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med. 2013;62:132–44. https://doi.org/10.1016/j.freeradbiomed.2013.01.018.

Article  PubMed  CAS  Google Scholar 

Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, et al. Prevalence of Parkinson’s disease across North America. NPJ Park Dis. 2018;4:21 https://doi.org/10.1038/s41531-018-0058-0.

Article  CAS  Google Scholar 

Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C. The epidemiology of Parkinson’s disease. Lancet. 2024;403:283–92. https://doi.org/10.1016/s0140-6736(23)01419-8.

Article  PubMed  PubMed Central  Google Scholar 

Collaborators GN. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459–80. https://doi.org/10.1016/s1474-4422(18)30499-x.

Article  Google Scholar 

Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Park Dis. 2018;8:S3–s8. https://doi.org/10.3233/jpd-181474.

Article  Google Scholar 

Wang J, Dai L, Chen S, Zhang Z, Fang X, Zhang Z. Protein-protein interactions regulating α-synuclein pathology. Trends Neurosci 2024;47:209–26. https://doi.org/10.1016/j.tins.2024.01.002.

Article  PubMed  CAS  Google Scholar 

Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, et al. Neuropathology of non-motor features of Parkinson disease. Park Relat Disord. 2009;15:S1–5. https://doi.org/10.1016/s1353-8020(09)70769-2.

Article  Google Scholar 

Cattaneo C, Jost WH. Pain in Parkinson’s disease: pathophysiology, classification and treatment. J Integr Neurosci. 2023;22:132. https://doi.org/10.31083/j.jin2205132.

Article  PubMed  Google Scholar 

Terracciano A, Luchetti M, Karakose S, Stephan Y, Sutin AR. Loneliness and risk of Parkinson disease. JAMA Neurol. 2023;80:1138–44. https://doi.org/10.1001/jamaneurol.2023.3382.

Article  PubMed  PubMed Central  Google Scholar 

Ou R, Lin J, Liu K, Jiang Z, Wei Q, Hou Y, et al. Evolution of apathy in early Parkinson’s disease: A 4-years prospective cohort study. Front Aging Neurosci. 2020;12:620762. https://doi.org/10.3389/fnagi.2020.620762.

Article  PubMed  CAS  Google Scholar 

Broen MP, Narayen NE, Kuijf ML, Dissanayaka NN, Leentjens AF. Prevalence of anxiety in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2016;31:1125–33. https://doi.org/10.1002/mds.26643.

Article  PubMed  Google Scholar 

Goldman JG, Sieg E. Cognitive impairment and dementia in Parkinson disease. Clin Geriatr Med. 2020;36:365–77. https://doi.org/10.1016/j.cger.2020.01.001.

Article  PubMed  Google Scholar 

Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323:548–60. https://doi.org/10.1001/jama.2019.22360.

Article  PubMed  Google Scholar 

de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35. https://doi.org/10.1016/s1474-4422(06)70471-9.

Article  PubMed  Google Scholar 

Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP. Environmental risk factors and Parkinson’s disease: An umbrella review of meta-analyses. Park Relat Disord. 2016;23:1–9. https://doi.org/10.1016/j.parkreldis.2015.12.008.

Article  Google Scholar 

Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson’s disease. Lancet. 2024;403:293–304. https://doi.org/10.1016/s0140-6736(23)01478-2.

Article  PubMed  CAS  Google Scholar 

Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P. Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:73. https://doi.org/10.1038/s41392-023-01353-3.

Article  PubMed  PubMed Central  Google Scholar 

Jyothi HJ, Vidyadhara DJ, Mahadevan A, Philip M, Parmar SK, Manohari SG, et al. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta. Neurobiol Aging. 2015;36:3321–33. https://doi.org/10.1016/j.neurobiolaging.2015.08.024.

Article  PubMed  CAS  Google Scholar 

Cerri S, Mus L, Blandini F. Parkinson’s disease in women and men: what’s the difference?. J Park Dis. 2019;9:501–15. https://doi.org/10.3233/jpd-191683.

Article  Google Scholar 

Zhu J, Cui Y, Zhang J, Yan R, Su D, Zhao D, et al. Temporal trends in the prevalence of Parkinson’s disease from 1980 to 2023: a systematic review and meta-analysis. Lancet Healthy Longev. 2024;5:e464–e479. https://doi.org/10.1016/s2666-7568(24)00094-1.

Article  PubMed  Google Scholar 

Marras C, Canning CG, Goldman SM. Environment, lifestyle, and Parkinson’s disease: Implications for prevention in the next decade. Mov Disord. 2019;34:801–11. https://doi.org/10.1002/mds.27720.

Article  PubMed  Google Scholar 

Chen R, Gu X, Wang X. α-Synuclein in Parkinson’s disease and advances in detection. Clin Chim Acta. 2022;529:76–86. https://doi.org/10.1016/j.cca.2022.02.006.

Article  PubMed  CAS  Google Scholar 

Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, et al. Assessment of heterogeneity among participants in the Parkinson’s Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023;22:407–17. https://doi.org/10.1016/s1474-4422(23)00109-6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G. Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson’s disease. Int J Mol Sci. 2020; 21:https://doi.org/10.3390/ijms21228421.

Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Mitochondrial dysfunction and mitophagy in Parkinson’s disease: from mechanism to therapy. Trends Biochem Sci. 2021;46:329–43. https://doi.org/10.1016/j.tibs.2020.11.007.

Article  PubMed  CAS  Google Scholar 

Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, et al. Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome. 2021;9:226. https://doi.org/10.1186/s40168-021-01107-9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell. 2019;18:e13031. https://doi.org/10.1111/acel.13031.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Biondetti E, Santin MD, Valabrègue R, Mangone G, Gaurav R, Pyatigorskaya N, et al. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease. Brain. 2021;144:3114–25. https://doi.org/10.1093/brain/awab191.

Article  PubMed  PubMed Central  Google Scholar 

Rathore AS, Birla H, Singh SS, Zahra W, Dilnashin H, Singh R, et al. Epigenetic modulation in Parkinson’s disease and potential treatment therapies. Neurochem Res. 2021;46:1618–26. https://doi.org/10.1007/s11064-021-03334-w.

Article  PubMed  CAS  Google Scholar 

Ding XS, Gao L, Han Z, Eleuteri S, Shi W, Shen Y, et al. Ferroptosis in Parkinson’s disease: Molecular mechanisms and therapeutic potential. Ageing Res Rev. 2023;91:102077. https://doi.org/10.1016/j.arr.2023.102077.

Article  PubMed  CAS